Reprieve Cardiovascular

📍 Milford, United States🗓 Founded 2020👥 24 employees💰 Last funded Nov 2023
Medical Equipment Manufacturing🌐 reprievecardio.com
Website LinkedIn
Reprieve Cardiovascular, Inc. is developing innovative and groundbreaking therapies that aim to improve the lives of more than 25 million heart failure patients around the world. Reprieve is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients. In 2022, Reprieve initiated the FASTR Trial (pilot study) to compare decongestive therapy administered by the Reprieve Decongestion Management System to Optimal Diuretic Therapy in the treatment of patients diagnosed with acute decompensated heart failure. Reprieve is a privately held medical device company, headquartered in Milford, Massachusetts, USA.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Reprieve Cardiovascular?
Reprieve Cardiovascular has 1 investors on record on gritt.io, 1 mid-stage.
When did Reprieve Cardiovascular last raise funding?
The most recent investment in Reprieve Cardiovascular recorded on gritt.io was in November 2023.
When was Reprieve Cardiovascular founded?
Reprieve Cardiovascular was founded in 2020.
What industry is Reprieve Cardiovascular in?
Reprieve Cardiovascular operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Reprieve Cardiovascular based?
Reprieve Cardiovascular is headquartered in Milford, United States.